Cargando…

First nosocomial infections in children supported by veno-arterial extracorporeal membrane oxygenation (VA-ECMO)

BACKGROUND: Veno-arterial Extracorporeal Membrane Oxygenation (VA-ECMO) is a standard procedure for patient with refractory shock in Pediatric Intensive Care Unit (PICU). There is a paucity of data on the time relationship between VA-ECMO support, nosocomial infection occurrence, and PICU length of...

Descripción completa

Detalles Bibliográficos
Autores principales: Cousin, Vladimir L., Rodriguez-Vigouroux, Robert, Karam, Oliver, Rimensberger, Peter, Posfay-Barbe, Klara M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948414/
https://www.ncbi.nlm.nih.gov/pubmed/36823601
http://dx.doi.org/10.1186/s12887-023-03908-3
_version_ 1784892776226226176
author Cousin, Vladimir L.
Rodriguez-Vigouroux, Robert
Karam, Oliver
Rimensberger, Peter
Posfay-Barbe, Klara M.
author_facet Cousin, Vladimir L.
Rodriguez-Vigouroux, Robert
Karam, Oliver
Rimensberger, Peter
Posfay-Barbe, Klara M.
author_sort Cousin, Vladimir L.
collection PubMed
description BACKGROUND: Veno-arterial Extracorporeal Membrane Oxygenation (VA-ECMO) is a standard procedure for patient with refractory shock in Pediatric Intensive Care Unit (PICU). There is a paucity of data on the time relationship between VA-ECMO support, nosocomial infection occurrence, and PICU length of stay (LOS). The aim of this study was to determine the characteristics and impact of ECMO-related infections. METHODS: This is a retrospective study from 01/2008 to 12/2014, enrolling children with a VA-ECMO support for > 6 h. We recorded the first PICU infection during the VA-ECMO run, defined as a positive microbiological sample with clinical signs of infection or clinical signs of severe infection without positive sample. RESULTS: During the study period, 41 patients (25/41 male) were included, with a median age of 41.2 months (IQR 12.9–89.9) and a 53% mortality rate. Median time on VA-ECMO was 4.2 d (IQR 2–7.1), median PICU LOS was 14.7 d (IQR 4,7–26,9). Overall, 34% patients developed an infection, with an incidence of 60/1000 VA-ECMO days. Median time to first infection was 4 d (IQR 3–5), with Pseudomonas spp. being the most commonly detected microorganism (42%). Infected sites were ventilator-associated pneumonia (9/14), sternotomy infection (2/14), bloodstream (2/14) and urinary tract infections (1/14). Longer VA-ECMO support (> 5 d) (OR 5.9 (CI 95% 1.4–24.6; p = 0.01) and longer PICU stay (> 14 d) (OR 12 (95% CI 2.2–65.5; p = 0.004) were associated with infection. CONCLUSION: In this single-center study, we underlined the high proportion and early occurrence of infections in patient on VA-ECMO, mostly in the first week. As infection was an early event, it may prolong the duration of VA-ECMO support and PICU LOS. Further research is needed to better understand the impact of infections on VA-ECMO and develop prevention strategies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12887-023-03908-3.
format Online
Article
Text
id pubmed-9948414
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99484142023-02-24 First nosocomial infections in children supported by veno-arterial extracorporeal membrane oxygenation (VA-ECMO) Cousin, Vladimir L. Rodriguez-Vigouroux, Robert Karam, Oliver Rimensberger, Peter Posfay-Barbe, Klara M. BMC Pediatr Research BACKGROUND: Veno-arterial Extracorporeal Membrane Oxygenation (VA-ECMO) is a standard procedure for patient with refractory shock in Pediatric Intensive Care Unit (PICU). There is a paucity of data on the time relationship between VA-ECMO support, nosocomial infection occurrence, and PICU length of stay (LOS). The aim of this study was to determine the characteristics and impact of ECMO-related infections. METHODS: This is a retrospective study from 01/2008 to 12/2014, enrolling children with a VA-ECMO support for > 6 h. We recorded the first PICU infection during the VA-ECMO run, defined as a positive microbiological sample with clinical signs of infection or clinical signs of severe infection without positive sample. RESULTS: During the study period, 41 patients (25/41 male) were included, with a median age of 41.2 months (IQR 12.9–89.9) and a 53% mortality rate. Median time on VA-ECMO was 4.2 d (IQR 2–7.1), median PICU LOS was 14.7 d (IQR 4,7–26,9). Overall, 34% patients developed an infection, with an incidence of 60/1000 VA-ECMO days. Median time to first infection was 4 d (IQR 3–5), with Pseudomonas spp. being the most commonly detected microorganism (42%). Infected sites were ventilator-associated pneumonia (9/14), sternotomy infection (2/14), bloodstream (2/14) and urinary tract infections (1/14). Longer VA-ECMO support (> 5 d) (OR 5.9 (CI 95% 1.4–24.6; p = 0.01) and longer PICU stay (> 14 d) (OR 12 (95% CI 2.2–65.5; p = 0.004) were associated with infection. CONCLUSION: In this single-center study, we underlined the high proportion and early occurrence of infections in patient on VA-ECMO, mostly in the first week. As infection was an early event, it may prolong the duration of VA-ECMO support and PICU LOS. Further research is needed to better understand the impact of infections on VA-ECMO and develop prevention strategies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12887-023-03908-3. BioMed Central 2023-02-23 /pmc/articles/PMC9948414/ /pubmed/36823601 http://dx.doi.org/10.1186/s12887-023-03908-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Cousin, Vladimir L.
Rodriguez-Vigouroux, Robert
Karam, Oliver
Rimensberger, Peter
Posfay-Barbe, Klara M.
First nosocomial infections in children supported by veno-arterial extracorporeal membrane oxygenation (VA-ECMO)
title First nosocomial infections in children supported by veno-arterial extracorporeal membrane oxygenation (VA-ECMO)
title_full First nosocomial infections in children supported by veno-arterial extracorporeal membrane oxygenation (VA-ECMO)
title_fullStr First nosocomial infections in children supported by veno-arterial extracorporeal membrane oxygenation (VA-ECMO)
title_full_unstemmed First nosocomial infections in children supported by veno-arterial extracorporeal membrane oxygenation (VA-ECMO)
title_short First nosocomial infections in children supported by veno-arterial extracorporeal membrane oxygenation (VA-ECMO)
title_sort first nosocomial infections in children supported by veno-arterial extracorporeal membrane oxygenation (va-ecmo)
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948414/
https://www.ncbi.nlm.nih.gov/pubmed/36823601
http://dx.doi.org/10.1186/s12887-023-03908-3
work_keys_str_mv AT cousinvladimirl firstnosocomialinfectionsinchildrensupportedbyvenoarterialextracorporealmembraneoxygenationvaecmo
AT rodriguezvigourouxrobert firstnosocomialinfectionsinchildrensupportedbyvenoarterialextracorporealmembraneoxygenationvaecmo
AT karamoliver firstnosocomialinfectionsinchildrensupportedbyvenoarterialextracorporealmembraneoxygenationvaecmo
AT rimensbergerpeter firstnosocomialinfectionsinchildrensupportedbyvenoarterialextracorporealmembraneoxygenationvaecmo
AT posfaybarbeklaram firstnosocomialinfectionsinchildrensupportedbyvenoarterialextracorporealmembraneoxygenationvaecmo